Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
Some of the most well-known GLP-1 receptor agonists include: Semaglutide (Ozempic, Wegovy): Originally developed for diabetes management, semaglutide has shown significant weight loss results
One of the key industry tailwinds supporting Lexaria is a growing shift in focus within the GLP-1 space from weight loss efficacy, towards tolerability and long-term drug adherence
The aqueous layer was discarded and the remaining water was removed with anhydrous sodium sulphate before samples were transferred to GC-MS vials
Lysine, though a weaker nucleophile than cysteine or histidine, reacts with anhydrides, imidates, and aldehydes (forming Schiff bases reducible to stable secondary amines), making it a useful handle for chemical labeling